PMC:4718081 / 18385-19201 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/4718081","sourcedb":"PMC","sourceid":"4718081","source_url":"https://www.ncbi.nlm.nih.gov/pmc/4718081","text":"Contribution of biomarkers to mini network disruption\nThe biomarker contribution to the mini network disruption is given in the Figure 9. For the single marker, P-tau is the major contributor to the mini network in the disease progression in both AD and MCI. However, effects of other two markers Aβ and tau on aggravating mini network disruption cannot be neglected at the end stage (at 48 month). The joint contribution of P-tau and Aβ may play a more important role in the deterioration of the disease.\nFigure 9 The percentage contribution to mini network disruption of the markers. Color-coded scale is used to present the percentage contribution to mini network disruption of the markers in this plot. The joint contribution of tau and P-tau as well as P-tau and Aβ both are potential vital factors of disease.","divisions":[{"label":"title","span":{"begin":0,"end":53}},{"label":"p","span":{"begin":54,"end":505}},{"label":"label","span":{"begin":506,"end":514}}],"tracks":[]}